The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

May 17, 2024

Study Completion Date

May 17, 2024

Conditions
Type1diabetesHypoglycemiaType 1 Diabetes
Interventions
OTHER

Infusion of GIP[1-42], GIP[1-30] or placebo

This is a single arm study. All participants will go through all five experimental days in a randomized order. The interventions are A) 4pmol/kg/min GIP\[1-42\] B) 8pmol/kg/min GIP\[1-42\] C) 4pmol/kg/min GIP\[1-30\] D) 8pmol/kg/min GIP\[1-30\] E) Saline (placebo)

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup

All Listed Sponsors
collaborator

The Novo Nordisk Foundation Center for Basic Metabolic Research

OTHER

lead

University Hospital, Gentofte, Copenhagen

OTHER